Literature DB >> 33249463

Rheumatic heart disease and COVID-19.

Andrea Beaton1, Liesl Zühlke2,3, Jeremiah Mwangi4, Kathryn A Taubert5.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 33249463     DOI： 10.1093/eurheartj/ehaa660

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  4 in total

1.  Impact of COVID-19 on pregnant women with Rheumatic heart disease or Peripartum cardiomyopathy.

Authors:  Arundhati Tilve; Niraj N Mahajan; Ankita Pandey; Bhargavi Jnanananda; Sangram Gadekar; Smita D Mahale; Rahul K Gajbhiye
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2021-01-18       Impact factor: 2.435

2.  Cardiovascular manifestations of COVID-19: A case series.

Authors:  Nidhi Kaeley; Hannah J Chawang; Himanshi Baid; Aadya Pillai
Journal:  J Family Med Prim Care       Date:  2021-11-05

Review 3.  The "Cairo Accord"- Towards the Eradication of RHD: An Update.

Authors:  Susy Kotit; David I W Phillips; Ahmed Afifi; Magdi Yacoub
Journal:  Front Cardiovasc Med       Date:  2021-07-02

4.  Secondary prevention of rheumatic heart disease in Ethiopia: a multicenter study.

Authors:  Wubishet Belay; Azene Dessie; Hayat Ahmed; Etsegenet Gedlu; Abinet Mariyo; Abdulkadir Shehibo; Zemene Tigabu; Muktar H Aliyu; Jonathan Soslow
Journal:  BMC Cardiovasc Disord       Date:  2022-02-02       Impact factor: 2.298
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.